These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 6122371)

  • 1. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the kallikrein-kinin system in the renal effects of angiotensin-converting enzyme inhibition in anaesthetized dogs.
    Clappison BH; Anderson WP; Johnston CI
    Clin Exp Pharmacol Physiol; 1981; 8(5):509-13. PubMed ID: 6276063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prostaglandins in the renal response to angiotensin-converting enzyme inhibition and renal artery occlusion.
    van Leeuwen BH; Anderson WP; Johnston CI
    J Cardiovasc Pharmacol; 1983; 5(5):883-8. PubMed ID: 6195481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.
    Campbell DJ
    Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):903-11. PubMed ID: 8846511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
    Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
    Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
    Heller J; Kramer HJ; Horácek V
    Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension.
    Bjørnstad-Ostensen A; Berg T
    Br J Pharmacol; 1994 Dec; 113(4):1567-73. PubMed ID: 7889314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
    Nasjletti A; Colina-Chourio J; McGiff JC
    Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225).
    Matthews PG; Johnston CI
    Adv Exp Med Biol; 1979; 120B():447-57. PubMed ID: 390990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal response to angiotensin-converting enzyme inhibition.
    Hollenberg NK
    Am J Cardiol; 1982 Apr; 49(6):1425-9. PubMed ID: 6176107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J; Rigter B; Földes-Filep E
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
    Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
    Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal, adrenal and vascular changes during inhibition of converting enzyme with captopril.
    Clappison BH; Millar JA; Casley DJ; Anderson WP; Johnston CI
    Clin Exp Pharmacol Physiol; 1980; 7(5):493-8. PubMed ID: 6256104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.